Boston Millennia Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
KorioOct 2023
Korio is a clinical technology company offering a randomization and trial supply management (RTSM/IRT) platform for trial sponsors.
Doylestown, US
Ryan Keane(Executive Officer, Director)Chuck Harris(Executive Officer, Director)
BoardAustin Poole(Director)Hugh R. Roome(Director)B. Bobby Bahram(Director)
Co-investorsBIP VenturesExcelerate Health Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.